- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Making LDL Matter Again: Addressing Clinical, Patient, and Payer Barriers in ASCVD Management
Panelists discuss how persistent undertreatment, shifting guidelines, therapy access barriers, and economic burden all contribute to poor LDL-C control, underscoring the need for renewed focus on outcomes-driven strategies to reduce cardiovascular risk.
Panelists discuss how: LDL-C control remains a national crisis, with many patients not on therapy or failing to reach target levels despite the availability of effective treatments.
Watch
EP. 2: Challenges with Undertreatment in Hyperlipidemia and Opportunities to Address this Gap
Panelists discuss how: clinical inertia, patient apathy, and the asymptomatic nature of high cholesterol all contribute to undertreatment and poor outcomes.
Watch
EP. 3: Pharmacy-Driven Challenges
Panelists discuss how pharmacy-related delays and limited escalation practices widen LDL-C management gaps.
Watch
EP. 4: Real-World Insights and PROMPT-LIPID
Panelists discuss how real-world programs like PROMPT-LIPID expose undertreatment patterns and guide care improvement.
Watch
EP. 5: Social Determinants of Health
Panelists discuss how social determinants such as access, income, and literacy drive disparities in LDL-C control.
Watch
EP. 6: The 2013 Guideline Shift
Panelists discuss how removing LDL-C targets in 2013 shifted focus from outcomes to statin use, weakening control efforts.
Watch
